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Abstract
Background:  Agaro-oligosaccharides derived from red seaweed polysaccharide have been
reported to possess antioxidant activity. In order to assess the live protective effects of agar-
oligosaccharides, we did both in vitro and in vivo studies based on own-made agaro-oligosaccharides,
and the structural information of this oligosaccharide was also determined.
Method: Structure of agaro-oligosaccharides prepared with acid hydrolysis on agar was confirmed
by matrix-assisted ultraviolet laser desorption ionization time of flight mass spectrometry (MALDI-
TOF-MS) and NMR. The antioxidant effect of agaro-oligosaccharides on intracellular reactive
oxygen species (ROS) was assessed by 2', 7'-dichlorofluorescin diacetate. Carbon tetrachloride was
used to induce liver injury, some index including SOD, GSH-Px, MDA, AST, ALT were examined
to determine the hepatoprotective effect of agaro-oligosaccharides.
Results: Agaro-oligosaccharides we got were composed of odd polymerizations with molecular
weights ranged from 500 to 2500. Results from intracellular test indicated that agaro-
oligosaccharides could significantly scavenge the level of oxidants in the hepatocytes, more
beneficially, also associated with the improvement of cell viability In vivo studies of the antioxidant
effects on tissue peroxidative damage induced by carbon tetrachloride in rat model indicated that
agaro-oligosaccharides could elevate the activity of superoxide dismutase (SOD), glutathione
peroxidase (GSH-Px) and decrease the level of malondialdehyde (MDA), glutamate oxaloacetate
transaminase (AST), glutamic pyruvic transaminase (ALT) significantly. At 400 mg/kg, MDA level
reduced 44 % and 21 % in liver and heart, SOD and GSH-Px increased to highest in liver and serum,
while ALT level decreased 22.16 % in serum.
Conclusion: Overall, the results of the present study indicate that agaro-oligosaccharides can
exert their in vitro and in vivo hepatoprotective effect through scavenging oxidative damage induced
by ROS.
Background
Liver is the main organ involved in the metabolism of bio-
logical toxins and medicinal agents. Such metabolism is
always associated with the disturbance of hepatocyte bio-
chemistry and generation of ROS (reactive oxygen spe-
cies) [1]. Lots of liver damages ranging from subclinical
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icteric hepatitis to necroinflammatory hepatitis, cirrhosis,
and carcinoma have been proved to associate with the
redox imbalance and OS (oxidative stress) [2]. Therefore,
a potential novel approach, namely developing antioxi-
dant drugs to treat and protect liver injury and liver dis-
ease, has been proposed [3]. This strategy is aimed to
devise and incorporate antioxidants into the therapeutic
for control of viral infections or protecting body from
alcohol or other toxin damage. We think antioxidants are
able to reduce hepatic inflammation and fibrosis, thus
slowing or even preventing progression to cirrhosis. One
of such candidates is agaro-oligosaccharides prepared
from agar, which was chosen in the present study.
Agar was easily extracted from red algae and widely be
used as food and gelling agent with historic record of
more than a thousand years in China and Japan. In recent
years, agaro-oligosaccharides which derived from agarose
have been widely investigated in structures and bioactivi-
ties [4-8]. Many beneficial health properties of agaro-oli-
gosaccharides are attributed to their antioxidant activities.
For example, agaro-oligosaccharides have been proved to
possess antioxidative activities in scavenging hydroxyl free
radical, scavenging superoxide anion radical and inhibit-
ing lipid peroxidation in various chemical assays [9-11].
Enoki et al. [12] also reported that the agarobiose shows
the ability to suppress the expression of iNOS (inducible
nitric oxide synthase), an enzyme associated with the pro-
duction of NO. In our previous work, we also discussed
the indirect attenuate effect of agaro-oligosaccharides
towards oxidation of human liver cells induced by
antimycin A [13]. These reports exhibited the potential
prospects of agaro-oligosaccharides as functional ingredi-
ent to prevent the ROS related diseases. However, no
researches have been done about their antioxidant effect
in the in vivo system. Therefore, in order to evaluate the
ROS scavenging activity of agaro-oligosaccharides as well
as possible liver injury protection from OS with the
respects of degree of polymerization, we firstly prepared
agaro-oligosaccharides with different degrees of polymer-
izations, then use the compounds to examine the in vitro
and in vivo antioxidant effects depending on hepatocyte
cellular assay of H2O2 induced damage and experimental
rat model of carbon tetrachloride (CCl4) induced toxic
hepatitis.
Methods
Preparation of agaro-oligosaccharides
Agaro-oliogsaccharides were prepared by acid hydrolysis.
In order to evaluate the difference of DP of oligosaccha-
rides on bioactivity, hydrolysis solution was fractionated
by activated carbon column. After loading the hydrolysate
onto column, the column was washed with 2 liters water
to remove salts and monosaccharides. Followed this step,
the agaro-oligosaccharides fraction was eluted sequen-
tially with 8 %, 15 % and 25 % hydroalcoholic solution.
Each fraction from the column was concentrated under
reduced pressure and lyophilized.
Structural information of agaro-oligosaccharides
The average molecular weight of three fractions was meas-
ured as described by Somogyi et al. [14].
The nuclear magnetic resonance (NMR) spectra were
acquired on an AVANCEDMX-500-NMR spectrometer.
Samples were dissolved in D2O. 13C NMR spectra of 4%
(w/v) solutions were recorded at 35°C under 100.69
MHz. Proton decoupled 13C NMR chemical shifts were
measured in parts per million. For 1H-NMR, samples (7–
10 mg) were dissolved in D2O (0.5 ml), and spectra were
recorded at room temperature using a spectral width of
5.7 kHz, 90° pulse, an acquisition time of 4.4 s for 144
scans.
Mass spectrometry analysis was performed on a Bruker
Reflex III MALDI-TOF-MS (Bruker-Daltonik, Germany) in
the delayed extraction and positive mode. An accelerating
voltage and a reflectron voltage were set at 20 kV of 22.8
kV, respectively, during the measurements. 2, 5-Dihy-
droxybenzoic acid was used as matrix (20 mg/ml; 3:2
water/MeCN) and approximately 10–100 pg of the DP-H
agaro-oligosaccharide mixture was deposited as a mixture
together with the matrix on a stainless steel target, and
subsequently dried under reduced pressure. During the
experiments, the laser power was adjusted to a level just
above the threshold for formation of observable ions. The
results from 20 to 100 laser shots were summed for sam-
ple.
Measurement of intracellular ROS generation
Intracellular oxidant stress was monitored by measuring
changes in fluorescence resulting from intracellular probe
oxidation.
Human hepatocyte L-02 purchased from Chinese Insti-
tute of Biochemistry and Cell Biology was cultured in
RPMl-1640 medium with 20 % fetal bovine serum. Viable
cells (105/ml) were plated into a 96-well for 1 day. On the
day of the experiments, after removing the medium, the
cells were washed with PBS for three times and then incu-
bated with different doses of agaro-oligosaccharides in 5
% CO2 at 37°C for 2 h. After incubation, 20 μM DCFH-
DA was added for another 45 min. The DCFH-DA was
removed by washing the cells with PBS. 100 μM H2O2
were added into cells for 45 min and the fluorescence
change was monitored by fluorescence spectorphotome-
ter at λex = 475 nm, λem = 525 nm [15].Nutrition Journal 2006, 5:31 http://www.nutritionj.com/content/5/1/31
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Cell viability and cytotoxicity assessment
The cell viability was quantified using MTT assay. Briefly,
1 × 104 cells were seeded in each well of microtiter plate
and allowed to attach overnight. Cells were treated with
various doses of agaro-oligosaccharides for different
period according to the experiment purpose. For cytotox-
icity test, the hepatocyte L-02 was treated for 48 h. But for
the detection of protective effect of agaro-oligosaccharides
on H2O2 damage, the L-02 was only treated for 2 h, and
then 100 μM H2O2 was added for another 2 h. MTT in PBS
was added to each well, followed by incubation for 4 h at
37°C. The formazan crystals were dissolved in DMSO.
The optical density was determined with a microculture
plate reader at 492 nm [16].
Animals model
Mature Wistar rats weighing 150 ± 20 g were supplied by
the animal center of Hangzhou, China. The animals were
housed in a room with a 12 h light/dark cycle at about
22°C and fed on standard diet with ad libitum access to
drinking water. All treatments were conducted between
9:00 am and 10:00 am to minimize variations. In this
study, rats were randomly divided into six groups. Group
1 (control, n = 8): water for 10 days followed by adminis-
tration of liquid paraffin only; group 2 (CCl4, n = 8): water
for 10 days followed by administration of CCl4 on the
final day; group 3 (positive control, n = 8): vitamin C (200
mg/kg) + CCl4; group 4 to 6 (n = 8): agaro-oligosaccha-
rides (200, 400, 600 mg/kg, respectively) + CCl4. Rats
were injected i.p. with vitamin C or agaro-oligosaccha-
rides for ten consecutive days. On the final day, all animal
except control group were administered with 20 % CCl4 in
liquid paraffin at a dose 5 ml/kg to induce hepatotoxicity.
Previous studies demonstrated that the OS indexes could
reach a maximum at 48 h after CCl4 i.p. administration
[17], therefore, in this work rats were sacrificed by collect-
ing the blood from the carotid artery after 48 h of admin-
istration. Two organs (liver and heart) were excised
immediately.
Biochemical assays
Serum was separated by centrifugation at 1000 × g at 4°C
for 10 min. 10 % organ homogenates including liver and
heart were prepared in ice-cold isotonic physiological
saline. The GSH-Px, MDA, SOD, AST and ALT levels of tis-
sue and serum were measured by spectrophotometric
methods as described in the assay kits.
Statistical analysis
All data are expressed as mean ± SD. In cell based assay,
the control and agaro-oligosaccharides treated cells were
compared by student t-test. In animal assay, the statistical
tests were one-way ANOVA followed by post-hoc New-
man-Keuls multiple comparisons test. A probability level
of 0.05 was considered statistically significant.
Results
Preparation and structure analysis of agaro-
oligosaccharides
Activated charcoal column has been performed as saccha-
ride isolation tool for decades. Depending on this tech-
nology, we successfully achieved to isolate three fractions
of agaro-oligosaccharides with average molecular weight
of 619, 1126 and 1631, respectively, eluted by 8 %, 15 %
and 25 % aqueous alcoholic solution. We use these three
fractions for the following experiments, designated as DP-
L, DP-M and DP-H, according to their differences in
molecular weight.
Since agar is a linear copolymer of galactose (G), alter-
nated with 3, 6-anhydrogalactose (A), the structural differ-
ence of agaro-oligosaccharides are mainly related with the
degree of polymerization. In this report, the 1H-NMR and
13C-NMR spectra of agaro-oligosaccharides was studied
using acid hydrolyzed fragments, and typical deshielded
1H-NMR and 13C-NMR signals corresponding to the ano-
meric hydrogens and carbons were obtained and pre-
sented in Fig. 1. Assignments were based on the close
similarity with literature values, and the interpretation of
these signals was indicated in Table 1. The spectra give out
twelve distinctive major anomeric carbon signals which
were expected for the major disaccharide repeat unit. The
presence of these signals demonstrates the presence of flo-
ridean starch in this fraction, because all of the signals
illustrated the galactose ring structures present in seaweed
galactans [18,19]. The 13C NMR spectrum of oligosaccha-
ride are very consistent with those previously published
for neoagarose series, with chemical shifts of carbons of
unit G'-1α and G'-1β appeared at identically 92.4 and
96.4 ppm, having intensities in the ratio of 1 : 2. While,
from the result, we didn't observe any signal for 3, 6-anhy-
drogalactose at the non reducing ending (a peak at 91.4
ppm) [20-22]. These results reflect the presence of galac-
tose units at the reducing ends of the reaction products,
but no 3, 6-anhydrogalactose at non-reducing end.
We applied MALDI-TOF-MS in order to know the struc-
tural information of composition and DP in the agaro-oli-
gosaccharide fractions which were obtained from
hydrolysis. The results shown in Fig. 2 indicated that a
large number of well-regulated peaks are present, and
these agaro-oligosaccharide ions could be identified as
series of sodium molecular ions with relatively high inten-
sities corresponded to 509, 815, 1121, and so on. It can be
seen, by comparing these ions, that the molecular mass
difference between every two adjacent ion is the same as
306 Da. This molecular mass difference of 306 Da is the
exact molecular mass of agaro-biose (GA), the basic struc-
tural unit, which is 324 Da, minus 18, which is the
number of H2O's molecular weight, therefore, it is clearly
observed that the agaro-oligosaccharides had very regularNutrition Journal 2006, 5:31 http://www.nutritionj.com/content/5/1/31
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molecular structures with gradient increase of its chain
length with the polymerization unit of agarobiose. Fur-
ther calculation for m/z 509, the lowest high intensity ion
observed in the mass spectrum, found that m/z 509 corre-
sponds to the sodium adduct of agarotriose (GAG)
[Mtri+Na]+. Based on this information, the ion at m/z 815,
1121, 1427.... corresponds to agaro-oligosaccharides for n
= 5, 7, 9..., respectively with galactose at both reducing
end and non-reducing end. For agaro-oligosaccharides,
two forms of saccharides exist depending on the end sugar
moiety, namely, neoagaro-series with 3, 6-anhydro-galac-
tose at the non-reducing end and agaro-series with galac-
tose at the non-reducing end. The results obtained here
indicated that our sample obtained belong to agaro-series
with odd numbers of sugar unit.
The antioxidant action of agaro-oligosaccharides in cell 
based assay
We firstly investigated the antioxidant activities of agaro-
oligosaccharides in the cellular system. DCFH-DA, which
can be conversed from non-fluorescence into fluorescence
through oxidation, was used as fluorescent probe to mon-
itor the changes of oxidative stress in hepatocyte L-02
induced by addition of H2O2. In our experiment, all the
measurements were carried out at the steady stage (incu-
bation time, 60 min) in order to minimize variations,
because it has been reported that treatment of H2O2 will
lead to the abruption of ROS in few minutes, and then
decrease to a steady stage [23].
Fig. 3 showed that addition of agaro-oligosaccharides
caused concentration-dependent attenuation of DCF flu-
orescence. Three groups of agaro-oligosaccharides showed
almost no inhibitory activity at the 125 μg/ml. When the
concentration increased, DP-H expressed highest activity,
followed by DP-M, much weaker for DP-L group, which
indicating that the antioxidant bioactivity in vitro
improves with the higher degree of polymerization of
agaro-oligosaccharide. Fig. 4 is a typical fluorescent micro-
scopic picture of the DCF fluorescence in hepatocyte L-02
1H-NMR and 13C-NMR spectra of solid acid hydrolysate Figure 1
1H-NMR and 13C-NMR spectra of solid acid hydrolysate.
A
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treated with DP-H. It is obvious that H2O2 lead to the pro-
duction of ROS, which transformed the DCFH into DCF
(Fig. 4D), showing more fluorescent cells than untreated
cells (Fig. 4A). DP-H additions decreased the free radical
formation. Fig. 4B clearly illustrated that DP-H at concen-
tration of 1 mg/ml could inhibit the oxidation of DCFH
significantly. While with the concentration decreased to
125 μg/ml (Fig. 4C), the number of fluorescent cells was
also increased, and which means that the antioxidant
activity of agaro-oligosaccharides acts in a concentration-
dependent manner.
Protective effect of agaro-oligosaccharides on oxidative 
stress injury
Oxidative stress is an important factor to induce the cell
death. Cell viability assay showed that the presence of
H2O2 (100 μM) resulted in cell death ratio increasing to
60 % after 2 h of treatment (Fig. 5). Compared to H2O2
alone, cell death was reduced obviously when exposed to
each agaro-oligosaccharide group at the higher concentra-
tions (from 500 μg/ml to 1 mg/ml). The cell viability sig-
nificantly increased to 64.26 % for DP-M treated cells at
the concentration of 1 mg/ml (Fig. 5). At low concentra-
tions (125 μg/ml to 500 μg/ml), there was almost no var-
iation observed between the agaro-oligosaccharide treated
cells and the control, except DP-M treated group showing
some weak cell protective effect. These results demon-
strated that the antioxidant activities of agaro-oligosac-
charides were positively correlated with the improvement
of the cell viability.
In order to test whether agaro-oligosaccharides affected
the growth of human hepatocyte L-02 without H2O2 treat-
ment, cell proliferation was assessed by direct MTT assay.
The cells were incubated with various amounts of agaro-
oligosaccharides for 48 h, and the change in cell number
was determined by analyzing the values of cells treated
with agaro-oligosaccharide versus that of control (Fig. 6).
From result, we found that compared with control group,
the agaro-oligosaccharides exhibited very slight effects on
the cell growth. After 48 h of treatment, the growth is
slightly inhibited as of 14.18 % for DP-H at 1 mM, while
for DP-M and DP-H, the corresponding cell proliferation
ratio was >100 % with concentration ≤ 250 μM, which
means that, at proper concentration, the agaro-oligosac-
charides can promote the proliferation of L-02 cells.
Therefore, the cell survival effect of agaro-oligosaccharide
alone in the antioxidation cellular assay can be considered
almost naught because the cells were only treated for 2 h,
so we concluded that agaro-oligosaccharides can effec-
tively protect the cells from oxidation induced death
through scavenging intracellular oxidative damage
induced by ROS.
Effect of agaro-oligosaccharides on an acute CCl4 
oxidative damage
We further studied the in vivo antioxidant effects of agaro-
oligosaccharides. It was not uncommon that compounds
possessing in vitro activity, however, fail to maintain the
activity when administrated into body. We established an
oxidative animal model by CCl4 injection. Considering
the proliferation and antioxidant effects of agaro-oligosac-
charides on hepatocyte, we used the mixture of DP-M and
DP-H as our sample for animal test. The effects of agaro-
oligosaccharides on oxidative stress in rats were estimated
by determining the activities of MDA, SOD, GSH-Px, ALT
and AST in serum and tissues.
MDA level is a main marker of endogenous lipid peroxi-
dation [24]. In CCl4  treated group, the MDA level
increased significantly in liver (F = 2.087, P < 0.05), but
little difference was observed in serum, which confirmed
that the toxicity of CCl4 is focused in the liver. By contrast,
MDA level in the agaro-oligosaccharides treated groups
decreased significantly compared with CCl4 treated group.
At 400 mg/kg, the MDA level reduced at least 44 % and 21
% in liver (F = 4.274, P < 0.05) and heart, respectively, ver-
sus the CCl4 treated group. Actually, the MDA level of
agaro-oligosaccharides treated groups showed almost the
same as the blank control group (Table 2). It provided the
Table 1: Chemical shift assignments for 1H-NMR and 13C-NMR spectra of agaro-oligosaccharides
Unit Chemical shifts (ppm)
C-1 C-2 C-3 C-4 C-5 C-6
Carbon G a 1 0 2 . 3 7 0 . 68 2 . 36 8 . 77 5 . 26 1 . 2
A b 98.1 69.9 79.7 77.1 75.5 69.4
Proton G 4.39 3.79 3.6 4.12 3.55 3.63 c/3.67 d
A 4.97 3.96 4.37 4.48 4.4 3.84 e/4.06 f
a galactose.
b anhydrogalactose.
c A-6 exo proton
d A-6'endo proton
e G-6 proton
f G-6' protonNutrition Journal 2006, 5:31 http://www.nutritionj.com/content/5/1/31
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information that exhibiting a very successful block of lipid
oxidation.
SOD and GSH-Px are intracellular antioxidant enzymes
that protect against oxidative process [25]. As show in
Table 3 and 4, a single high dose injection of CCl4 induced
severe oxidative damage and the SOD and GSH-Px level
decreased markedly. While various concentrations of
agaro-oligosaccharides could effectively normalize the
enzyme activities and the two indexes were even higher
than Vitamin C group. In liver and serum, the SOD level
reached to highest at 400 mg/kg (F = 3.878, P < 0.05; F =
9.363, P < 0.05). Similar results were obtained in case of
the GSH-Px activities.
Serum levels of transaminases (ALT, AST) were used as
indicators to evaluate the attribution of agaro-oligosac-
charides to the structure damage of the liver [26,27]. In
this experiment, the enzyme assays of serum transami-
nases showed that a toxic dose of CCl4 significantly raised
the levels of ALT and AST to 687 (F = 3.761, P < 0.05) and
415 U/l (F = 4.204, P < 0.05). Agaro-oligosaccharides
could inhibit the enzyme activities effectively. The ALT
level reached to minimum when the sample concentra-
tion was 400 mg/kg (22.16 % less than the control
group). For AST, the agaro-oligosaccharides reduce it in a
dose dependent manner. At the highest concentration
(600 mg/kg), AST level decreased to 222 U/l. However, it
is strange to find that Vitamin C didn't reduce AST but
raised it to 32 % versus the control without CCl4 treatment
(Fig. 7).
Discussion
Among therapeutics for liver diseases, protective drugs
have been attracted more and more attentions, such as
antioxidant prevention approaches. In this paper, we
MALDI-TOF mass spectrum of agar hydrolysate Figure 2
MALDI-TOF mass spectrum of agar hydrolysate. (m/z 400–2700).Nutrition Journal 2006, 5:31 http://www.nutritionj.com/content/5/1/31
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focused on the in vitro and in vivo antixoidative activities
of agaro-oligosaccharides with the model related with
liver disease.
Agaro-oligosaccharides are linear oligomers cleaved from
agar which is built of 1, 4-linked 3, 6-anhydro-α-L-galac-
tose alternating with 1, 3-linked β-D-galactopyranose.
When agar is attacked by degradation reagents, such as
hydrolysis enzyme, acid or alkali, numerous possibilities
for combination, viz., the repetition of AG, GA, AGA, or
GAG, etc will exist. In this research, depending on NMR
and MALDI-TOF-MS analysis, we detected the precise
structural features of our hydrolysate. NMR results give us
information that our product is agarose structure, further-
more, there was no signal of A at reducing end. In the
spectrum of MALDI-TOF-MS, the first high intensity peak
observed at m/z 509 was assigned to (Mtri+Na)+ contain-
ing two galactopyranose (Galp) residues and one 3,6-
anhydrogalactopyranose (AnGalp) residues, followed by a
series of agaro-oligosaccharides: agaropentaose, agaro-
heptanose, agarononaose, and so forth. In our case, the
agaro-oligosaccharides with odd polymerization degree
were dominant.
For the in vitro antioxidant studies, we noticed that agaro-
oligosaccharides expressed different antioxidant abilities
with different ranges of DPs. In them, the fraction of DP-
H with average MW of 1631 showed highest free radical
scavenging activity which agrees well with the result
obtained by Zhao et al. [10]. However, Enoki et al. [12]
found, in a different assay system, that agarobiose pos-
sessed the highest ability to inhibit the expression of
Effect of agaro-oligosaccharides on DCF fluorescence in hepatocytes Figure 3
Effect of agaro-oligosaccharides on DCF fluorescence in hepatocytes. Values expresses as mean ± SD. n = 6. * P < 
0.05, ** P < 0.01, vs control cells without sample.
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iNOS. Therefore, comparison of structure-bioactivity in
vitro for different studies should be careful bearing differ-
ent assays in mind.
It is quite significant that the in vivo animal experiment for
agaro-oligosaccharides is quite consistent with the in vitro
assays. Besides successful protection of liver damage by
efficiently inhibiting MDA formation and decreasing AST
and ALT, agaro-oligosaccharides enhance the activities of
antioxidant enzyme system of the host, including SOD,
GSH-Px. We also notice that vitamin C only slightly
reduced AST and ALT level in rats in our experiment,
although it prevented MDA formation effectively (Fig. 7).
The result indicates that agaro-oligosaccharides have bet-
ter impact to improve the hepatoprotective ability. Since
antioxidant enzymes such as SOD and GSH-Px are consid-
ered to be a primary defense system for oxidative damage
prevention, agaro-oligosaccharides exert antioxidant not
only through its own radical scavenging activity, but also,
by boost the host antioxidant enzyme system. On the
other hand, we found that when the sample concentration
increased from 400 mg/kg to 600 mg/kg, several indexes
showed a different change. At concentration of 600 mg/
kg, the MDA level increased slightly and SOD, GSH-Px
and AST activities reduced a little. This result implied that
excessive administration of agaro-oligosaccharides will
decrease their antioxidant ability with unknown reasons.
Inhibition of intracellular oxidant by agaro-oligosaccharides Figure 4
Inhibition of intracellular oxidant by agaro-oligosaccharides. (A) Control without H2O2, (B) 1 mg/ml 25% ethanol 
eluted fraction, (C) 125 μg/ml 25% ethanol eluted fraction, (D) Positive control.
A B
C DNutrition Journal 2006, 5:31 http://www.nutritionj.com/content/5/1/31
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In conclusion, by carefully examining the antioxidant pro-
tective effects of agaro-oligosaccharides both in vitro and
in vivo, the agaro-oligosaccharides prepared via solid acid
hydrolysis showed consistent and concentration-depend-
ent antioxidation activities, as well as significant protec-
tion against liver injury.
Conclusion
These results support a beneficial relationship between
antioxidant activity and hepatoprotective effect of agaro-
oligosaccharides which belong to agaro-series with odd
numbers of sugar unit as their dominant composition.
Effect of agaro-oligosaccharides on cell survival during H2O2 exposure Figure 5
Effect of agaro-oligosaccharides on cell survival during H2O2 exposure. Values expresses as mean ± SD. n = 6, * P < 
0.05, ** P < 0.01, vs control.
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Table 2: Effect of agaro-oligosaccharides on MDA activity in different organs of CCl4 induced rats a
Groups Liver (nmol/mg prot) Heart (nmol/mg prot) Serum (nmol/ml)
Normal control 2.75 ± 0.51 0.56 ± 0.08 4.20 ± 0.22
CCl4 control 4.62 ± 0.77# 0.68 ± 0.05 4.44 ± 0.64
Vitamin C 2.59 ± 0.02* 0.67 ± 0.11 3.53 ± 0.74
G4 (200 mg/kg) 3.45 ± 0.77 0.54 ± 0.11 3.33 ± 0.11
G5 (400 mg/kg) 2.71 ± 0.18* 0.53 ± 0.14 3.36 ± 0.63
G6 (600 mg/kg) 2.99 ± 0.47 0.45 ± 0.02 2.82 ± 0.66
a n = 8. Each value represents the mean ± SD.
Significant values: *P < 0.05 (vs CCl4 group); #P < 0.05 (vs Normal group).
G4, G5 and G6: group 4, 5, 6 which administrated with sample of 200 mg/kg, 400 mg/kg and 600 mg/kg, respectively.Nutrition Journal 2006, 5:31 http://www.nutritionj.com/content/5/1/31
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Abbreviations
A: 3, 6-anhydrogalactose
DCFH-DA: 2', 7'-dichlorodihydrofluorescein diacetate
DP: degree of polymerization
DP-H: Degree of Polymerization-High, representing the
experiment group of the agaro-oligosaccharides with aver-
age molecular weight of 1631, eluted by 25 % ethanol
from the charcoal column
DP-L: Degree of Polymerization-Low, representing the
experiment group of agaro-oligosaccharides with average
molecular weight of 619, eluted by 8 % ethanol from the
charcoal column;
DP-M: Degree of Polymerization-Middle, representing the
experiment group of agaro-oligosaccharides with average
molecular weight of 1126, eluted by 15 % ethanol from
the charcoal column;
G: galactose;
MDA: malondialdehyde;
MTT: 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-
tetrazolium bromide
Effects of different concentrations of agaro-oligosaccharides on cell proliferation after exposure of cells for 48 h Figure 6
Effects of different concentrations of agaro-oligosaccharides on cell proliferation after exposure of cells for 48 
h. Values expresses as mean ± SD. n = 3
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Table 3: Effect of agaro-oligosaccharides on SOD activity in different organs of CCl4 induced rats a
Groups Liver (U/mg prot) Heart (U/mgprot) Serum (U/ml)
Normal control 34.18 ± 2.45 46.80 ± 2.84 313.77 ± 24.01
CCl4 control 26.97 ± 6.69# 27.71 ± 2.26# 306.89 ± 19.29
Vitamin C 33.11 ± 2.79* 32.75 ± 1.73 318.35 ± 16.39
G4 (200 mg/kg) 33.45 ± 2.87* 34.37 ± 1.34 361.08 ± 9.37*#
G5 (400 mg/kg) 38.64 ± 8.44* 37.33 ± 2.45 365.53 ± 21.13*#
G6 (600 mg/kg) 35.42 ± 2.86* 40.49 ± 2.21* 364.92 ± 14.21*#
a n = 8. Each value represents the mean ± SD.
Significant values: *P < 0.05 (vs CCl4 group); #P < 0.05 (vs Normal group).Nutrition Journal 2006, 5:31 http://www.nutritionj.com/content/5/1/31
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MW: molecular weight;
OS: oxidative stress;
ROS: reactive oxygen species
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Table 4: Effect of agaro-oligosaccharides on GSH-Px activity in different organs of CCl4 induced rats a
Groups Liver (NU/mgprot) Heart (NU/mgprot) Serum (× 103 NU)
Normal control 159.17 ± 6.97 200.20 ± 15.46 12.50 ± 1.44
CCl4 control 91.60 ± 3.97# 191.81 ± 36.90 10.38 ± 1.48#
Vitamin C 119.41 ± 9.86 204.86 ± 17.11 11.02 ± 0.66
G4 (200 mg/kg) 120.50 ± 17.05 203.63 ± 25.01 12.18 ± 1.95
G5 (400 mg/kg) 127.19 ± 12.17* 217.40 ± 10.82 13.13 ± 1.21
G6 (600 mg/kg) 118.92 ± 17.56 248.47 ± 39.28 12.26 ± 1.30
a n = 8. Each value represents the mean ± SD.
Significant values: *P < 0.05 (vs CCl4 group); #P < 0.05 (vs Normal group)
Effect of agaro-oligosaccharides on AST and ALT activity in serum Figure 7
Effect of agaro-oligosaccharides on AST and ALT activity in serum. Values expresses as mean ± SD. n = 8, #P < 0.05, 
vs Normal group. G4, G5 and G6: group 4, 5, 6 which administrated with sample of 200 mg/kg, 400 mg/kg and 600 mg/kg, 
respectively
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